577
1495583226014562115173
Ces37287936014570127174
Urol39277936014578115180208
2023;41607936014562121178238260
27(3):44457936014562119147205234256
139-15047277936014561113171211264316376
PŘEHLEDOVÉ3674207016974156235334409485586692777855
ČLÁNKY4576207016981154252352436525
25.624896013356110131
Furniss773896013353110144204229270312
D,110489601337291
Harnden1214896013371123157217278332391
P,162489601335867
Ali171089601336691115
N,184489601337194
et195689601335591
al.20658960133537799
Prognostic218389801315584140199256313352386407455
factors265789801312978126161216247288
for296489801312885116
renal309989801313283140188209
cell332789801314999121142
carcinoma.348889801314998128174195252309397445464
Cancer3972898013162110167215265295
Treatment428789801315074125172203291343400431
Reviews.4738898013155107155177228306345364
2008;6241048013154105160214231
34(5):8791048013154108137187214231
407–26.11341048013153108157206253304323
26.6241196013356110133
Kirkali787119601335986121173226252276
Z,1093119601336184
Lekili12061196013352107158185210235
M.14701196013389113
Renal16131198013156109167215238
cell18811198013149100123144
carcinoma:2056119801314999130177198256314404453470
new25571198013159112190
prognostic2778119801316092149209267325365400422470
factors?3279119801312879128164220252293329
Current36391198013163118149181233291323
Opinion39921198013174135157215237294353
in4375119801312381
Urology.44861198013169100157180238298347360
2003;48761198013154105160210226
13(6):624134801315498125175201218
433–8.8661348013154103152208263282
27.6241496013356109121
Rivet767149601336085138192228
J,1018149601334162
Mourah11021496013389150210245298359
S,1483149601335577
Murata15831496013388149184237272325
H,1931149601337295
et2049149601335591
al.2163149601335379101
VEGF22871498013156108175225
and25361498013150108167
VEGFR-127271498013155107175225278310357
are3107149801315081133
coexpressed32631498013149105159207267299351391431484544
by38311498013160108
epithelial39621498013153113136169227280303324372395
and43801498013150108167
stromal4571149801314175107164253302324
cells49191498013149100123144183
of624164801315987
renal735164801313284142191213
cell9721648013149100122144
carcinoma.1140164801314999130177199256315404453472
Cancer.16361648013163113170219270301315
2008;19751648013154106161215232
112(2):2231164801315494139164215241258
433–42.25131648013154103153208264313331
28.6241796013356111135
Bensalah7891796013360115176218272297349410
K,1229179601336085
Rioux‑Leclercq1345179601335985145206257288342396446471526562610670
N,2046179601337295
Vincendeau2172179601336188148197251311373428481540
S,2743179601335477
et2850179601335592
al.2972179601335379101
Is3104179801312362
tumour3198179801313492180239297328
expression35581798013153101161193244285324346403462
of4051179801315987
VEGF41701798013156108175225
associated4427179801315089129187237259307339390450
with49091798013179102135193
venous6241948013150102159218276315
invasion963194801312381128178217239296355
and13421948013150108167
survival1533194801314198129182205254304326
in1883194801312381
pT319881948013160104159
renal2171194801313284142190213
cell24081948013149100122144
carcinoma?2576194801314999130177199256314404453489
Progres3089194801315686143203234286326
En34391948013151109
Urologie.3572194801316999156179237297319372389
2007;39851948013154105160209222
17(2):4231194801315498121173199215
189–93.44701948013154101152210262312329
29.6242096013356111130
Kluger777209601336087147208263298
HM,10982096013372161185
Siddiqui1305209601335579141203228290349374
SF,17022096013355107119
Angeletti18442096013367128189244270325361400424
C,2291209601336488
et2402209601335592
al.2517209601335378101
Classification2641209801316385133173213234260287335385417439497555
of3220209801315987
renal3331209801313284142190213
cell35672098013149100123145
carcinoma3735209801314999130177199256315404453
based42122098013161111150203264
on44992098013159117
expression46402098013154101161193245285325346404463
of624224801315988
VEGF7442248013156109177227
and10042248013150108168
VEGF12042248013157109177227
receptors1464224801313284134186246279335368409
in1906224801312381
both20192248013161121154212
tumor2264224801313492182240273
cells25692248013150101124146185
and27862248013151109169
endothelial29872248013154112172231263322376398420469491
cells.35112248013149100123145185205
Laboratory37482248013150101161221253304336393425477
Investigation.4258224801312381129181222257279338388420443501560579
2008;48702248013154106161215233
88(9):6242398013154107135184210227
962–72.8752398013154108158210257309327
30.6242546013356112133
Klatte787254601336087139174213267
T,1084254601335470
Rossi11842546013359119162204229
SH,14432546013354125148
Stewart1621254601335488142222274310349
GD.20002546013371144163
Prognostic2194254801315586142202260319359393415463
factors2688254801312980128164220252293
and30122548013150108167
prognostic3210254801316193149210267326366400422471
models37112548013190149209262285323
for4065254801312986118
renal4214254801313284142191213
cell44582548013149100122144
carcinoma:4633254801314998130176198256314404453470
a6242698013150
literature69826980131234578129161211243300332383
review.1105269801313384133156208287302
World14312698013190145177200259
Journal1714269801313897155186245293316
of2054269801315887
Urology.2165269801316999156179237297346359
2018;25482698013154106153200217
36(12):27892698013154106134181226252269
1943–52.3082269801315398153202257308358376
31.6242846013356106123
Hodorova7722846013372132195255291350402455
I,1251284601332649
Solar13252846013354115140193228
P,1578284601335868
Mihalik16702846013388114174227252277328
J,2022284601334162
et2109284601335591
al.2225284601335378100
Investigation2350284801312381128180220255277336385417439497555
of2930284801315987
tumour3043284801313491180239297328
supressor3396284801314198157189241281321379411
protein3832284801316193150182233255312
p5341702848013160111161
in4357284801312380
renal4462284801313384142191213
cell47012848013149100122144
carci‑4870284801314999130177199232
noma6242998013159117207256
patients.9042998013161110143165217275307349368
Biomedical1296299801315678136225278339361409459481
Papers‑Olomouc.18012998013155103163217248289320397420478568626684733752
2014;25772998013154105153199216
158(1):2817299801315498150178226246262
44–9.31042998013153110167219234
32.6243146013356107129
Gudowska‑Sawczuk7723146013370129190248326368418470504555607684731779837887
M,16783146013387110
Kudelski18063146013359116177230255297346372
J,2197314601334060
Mroczko22763146013387122180228276326383
B.2678314601335980
The27773148013150109161
Role29573148013155111134185
of3161314801315885
Chemokine32663148013161118169257314359382438490
Receptor37753148013154106155204262294349380
CXCR341743148013162121178231283
and44773148013149105163
Its465931480131235596
Ligands4774314801314970128175232290328
in624329801312381
Renal7293298013155108166215237
Cell9903298013163114137158
Carcinoma.11723298013163113144191213270328418467486
International1682329801312381113164195254303335357415473522544
Journal2250329801313896154186244293315
of2590329801315886
Molecular27013298013185144167219269326348397428
Sciences.31533298013151100122175233281332372392
2020;35693298013154105155206225
21(22).38183298013153100122173226252267
33.6243446013356109130
Bratu773344601335995147182241
O,1034344601337594
Mischianu11473446013388114156205264289340400459
D,1626344601337291
Marcu17373446013387140175223282
D,2038344601337392
et2149344601335591
al.2259344601335378100
Renal23783448013155108165213235
tumor2633344801313491179237269
biomarkers2922344801316082139228277308353404435476
(Review).3418344801312983135183206258336362377
Experimental3815344801315199159213244266354406464495544566
and44013448013150107166
Therapeutic45873448013151110163194243302355412445467515
Medicine.6243598013186139199221269291348402419
2021;10673598013153105155202212
22(5).13033598013154107132182209224
34.6243746013356113135
Tschirdewahn785374601335591140200225260321376456509569630
S,1441374601335477
Panic15443746013359110170195244
A,1814374601336892
Pullen19333746013358117143168223283
L,2243374601335275
et2344374601335592
al.2462374601335378101
Circulating2590374801316385116163220242291323345403462
and30793748013150108167
tissue327337480131345695135192245
IMP335453748013123107162212
levels3784374801312476125177199238
are4049374801315082133
correlated42093748013149105137170221244292324375436
with46723748013179102135193
poor48923748013161120179211
survival624389801314197129182205254304326
in974389801312380
renal1079389801313283141190212
cell13153898013150100123145
carcinoma.1484389801314999130177198256314404453472
International1980389801312381112163195254302335357414473522544
Journal2548389801313896154185244293315
of2887389801315987
Cancer.29983898013163113171219270301316
2019;33383898013153105153198216
145(2):35783898013154100149175226252269
531–9.38713898013154104150199252267
35.6244046013356110130
Yang7834046013360107167229
F,1041404601335365
Song11354046013354115176237
Y,1401404601336075
Ge15054046013371127
L,1661404601335275
et1765404601335592
al.1886404601335378101
Long20164048013149106164224
non‑coding22704048013159117176209260316376398456515
RNAs28154048013156126189231
as3076404801315089
prognostic3195404801316193150210268326366400422471
biomarkers3696404801316183141230279311357408440481
in4207404801312380
papillary43174048013161111170193215237285316368
renal4715404801313384142191213
cell49584048013149100123144
carcinoma.624419801314999130177199256314404453472
Oncology11204198013174133181237260318379427
Letters.15714198013149101134171222253294314
2019.19094198013153105153198213
36.6244346013356112134
Felekkis7834346013353107133187239292319361
K,1168434601336085
Touvana12774346013355108168221274334387
E,1688434601335477
Stefanou1789434601335488142174227288348408
C,2221434601336488
Deltas23334346013374129155191244287
C.2644434601336488
microRNAs:27574348013190112160192248303373436478496
a32784348013150
newly33534348013159112190213261
described36394348013160113153201233256315369429
class4093434801314971120160199
of4317434801315987
encoded44294348013153111160216276329389
mole‑48434348013190149172225260
cules6244498013149106129181222
that870449801313492140173
play1067449801316084132179
a12704498013150
role1344449801313289112165
in1533449801312380
health16374498013159112160183216274
and19354498013150108167
disease.2126449801316082121174222262315332
Hippokratia.2482449801316991151211270316350400432454502521
2010;30274498013154106153200219
14(4):32704498013153100129178204220
236–40.35144498013154107159217273328345
37.6244646013356107117
Slaby760464601335478129190240
O,1018464601337594
Jancovicova1131464601334091150198256306331379436486538
J,1688464601334060
Lakomy17674646013351104154211301350
R,2136464601335882
et2237464601335490
al.234546460133537799
Expression2463464801315199158189239279317338395452
of2934464801315886
miRNA-10630394648013189110163232293324369415468
b35254648013160
in3604464801312380
conventional37034648013148103160206257314345366423480528549
renal4271464801313283140187209
cell4499464801314898120141
carcinoma4659464801314997128173194251308396444
is624479801312361
a7054798013149
potential7744798013160118150201258289310358380
marker11734798013190138168214265296
for1488479801312985117
prediction1624479801316092143202223271306328385443
of2086479801315886
early21924798013153100131153200
metastasis24124798013189142174223262296345384405443
after2875479801314977114164195
nephrectomy.30894798013159111170228258309358393449537583596
Journal3704479801313896153183241289311
of4035479801315886
Experimental41404798013151100159212243265353405462494543564
&47234798013161
Clinical4802479801316284105161182230279301
Cancer6244948013163112170219270301
Research.9494948013156109149202250281328386405
2010;13784948013154105153200218
29.16204948013154106121
38.6245096013356111134
Griffiths‑Jones7775096013370106131160190220255315357389424484544598641
S,1437509601335476
Saini15325096013354107131191216
HK,17675096013371130155
van19415096013353105165
Dongen21255096013373133193254308369
S,2513509601335476
Enright26085096013354113148173233293328
AJ.29555096013367110131
miRBase:31065098013190111165219269308361378
tools3504509801313489147170208
for3732509801312985117
microRNA38695098013189111159190245300370432
genomics.43215098013159111169226315337384425444
Nucleic47855098013170127175197249270318
Acids6245248013164112134193232
Research.8805248013156109149202250281328386405
2008;13095248013153105160214231
36:15645248013154106123
D154–D8.17125248013171118163216273345398418
39.6245396013356110129
Esquela‑Kerscher781539601335498160220275301353388449503538582632692747782
A,1592539601336792
Slack1712539601335480132181231
FJ.1972539601335384106
Oncomirs21075398013174133181237327349380421
–25575398013155
microRNAs26415398013190112160192248304374437479
with31495398013179102135193
a33715398013150
role3451539801313289112165
in3645539801312380
cancer.3755539801314998156205256287301
Nature40865398013170119151209240291
Reviews44075398013155108157180232311351
Cancer.47885398013162112170218269301315
2006;6245548013154105160215232
6(4):880554801315482131156173
259–69.10775548013154107155213270321336
40.6245696013356112134
Wang7775696013392141200261
F,1057569601335364
Zhang11405696013361119171230291
HX,14505696013371131155
Xu16245696013362118
NH,17615696013372142165
et1945569601335490
al.205456960133527799
A21725698013164
novel22555698013159116163214236
hypoxia‑induced25115698013158104164222267289336368391448506562610660719
miR-147a32505698013189111164196241287334378
regulates3647569801313283142199220268299349389
cell4056569801314898120141
proliferation4217569801316091147170190218269300349381402459517
through4753569801313491122177234293350
a6245848013150
positive6985848013161120160181215237286338
feedback1060584801312981135195254304353398
loop1482584801312482141201
of1707584801315887
stabilizing1818584801314176125185207229251295317375434
HIF-1.2276584801317092141173219231
Cancer25325848013162112170218269301
Biology2857584801315577135158216276325
&32015848013162
Therapy.32825848013151111164195245305352365
2016;36725848013153105153199216
17(8):3913584801315397120171198214
790–8.41515848013154104159217272291
41.6245996013356105122
Iwamoto7725996013326106159250310346405
H,1202599601337295
Kanda13225996013360114174236288
Y,1636599601335974
Sejima17365996013354109135160251303
T,2065599601335470
et2160599601335592
al.2277599601335378101
Serum24045998013151104136194283
miR-21027135998013190112166198245292339
as3078599801315090
a31945998013150
potential32705998013161120152203261293315363385
biomarker3681599801316184141231280311357409440
of4147599801315987
early42605998013154102133156204
clear4490599801314971124172203
cell47195998013150100123145
renal4890599801313284142190213
cell6246148013149100123144
carcinoma.792614801314999130177199256315404453472
International1288614801312481113164195254303335357415473522544
Journal1857614801313796154185244293315
of2196614801315887
Oncology.23076148013174133181237260318378427440
2014;27726148013153105152199216
44(1):30126148013153110138186206223
53–8.32596148013154103159214233
42.6246296013356108130
Iwamoto7736296013326106158248307343401
H,1193629601337194
Osaki13066296013376118171221248
M,15736296013388111
Honda17036296013372132192253305
M,20276296013388111
et2157629601335591
al.2267629601335378100
miR-21023866298013189111164196242288335
as2741629801314988
a28496298013150
Biomarker2918629801315677134223271302348399430
in3367629801312380
Renal34676298013155107165213235
Carcinoma.37216298013163112143189210267324413461480
Biomarkers4221629801315577134222271301347398429469
in4710629801312380
Kidney4810629801315478136193245292
Disease.624644801317194133186234274327344
2016;9926448013154105153199217
1–2:12336448013154103150168
895–910.14256448013154106157213265313360378
43.6246596013356110132
Lu7826596013352111
J,919659601334162
Wei10086596013393145170
JH,12056596013340112135
Feng13676596013353107167229
ZH,16226596013361131154
et1803659601335591
al.1921659601335378101
miR-10620486598013190112166199245292347
b-5p2414659801316096147205
promotes2646659801316193149239297330381421
renal3094659801313384142191213
cell33346598013149100123144
carcinoma3506659801314999130177198256314404453
aggressiveness39866598013150109169200251292331353402454512565605645
and46586598013150108167
stem­4853659801314175126215249
‑cell‑like624674801313384135157179212236258303354
phenotype10026748013161120173231289321373434488
by15146748013160108
activating1646674801315098134156206256288310367427
Wnt/beta‑catenin20976748013190146178220281335368418451502552584635693715772
signalling.2893674801314163122180228251272294351411429
Oncotarget.33466748013174133182238270320351409462495514
2017;38846748013154105153197210
8(13):4118674801315381129173198215
21461–71.43576748013154101147202247297344393406
44.6246896013356115137
Li789689601335277
YF,8946896013359113125
Chen10476896013364123178239
DQ,13146896013373149173
Su15146896013355114
ZM,16566896013361149173
et1856689601335592
al.1975689601335379101
MicroRNA-10621046898013186108156188244299369432464510557611
b27356898013160
functions2824689801312988145194230252310368408
as3260689801315090
an33796898013150107
oncogene35156898013159117166222282335393446
in3989689801312381
renal4098689801313384142191213
cell43406898013149100122144
carcinoma4513689801314999130177198256314404453
by49946898013161108
affecting624704801315079109161210246268326385
cell10337048013149100123145
proliferation,1202704801316092149172194222274305355388410467526544
migration17707048013190112171202252284306364423
and22177048013150107167
apoptosis.24087048013150109169229262318358379418437
Molecular28697048013186144168220270327349398429
Medicine33227048013186139199221269291349402
Reports.37487048013155109168227259296338358
2016;41307048013153105153199217
13(2):4371704801315398124176202218
1420–6.46147048013153100149200258315334
45.6247196013356110131
Papadopoulos7847196013359110172225287347410471531557617659
EI,1473719601335479102
Petraki16047196013358111147183236287313
C,1947719601336387
Gregorakis20647196013371107161223283319372423450492
A,2585719601336892
et2706719601335592
al.2827719601335378101
Clinical2957719801316385106164185234283306
evaluation32927198013154103152175232280312335392451
of3773719801315887
microRNA-14538907198013190111160191248303373436468514560609
expression45297198013154101162194245285325346404463
in5022719801312380
renal624734801313283140188210
cell854734801314999121142
carcinoma:1016734801314998129175196253311399448465
a15007348013150
promising1570734801316092147236258296317374432
molecular20227348013190147170222271328349397428
marker24707348013189138169214265296
for2786734801312885116
discriminating2922734801316081119168199221309330387435467488545604
and35467348013149106165
staging3731734801314175124182204261319
the4070734801313491144
clear4233734801314971123170201
cell4454734801314999121142
histological4616734801315980118153208231288347369416466487
subtype.624749801314197157190241302356373
Biological1021749801315678135159217277299347397419
Chemistry.14647498013163120173262284323358389441455
2016;19437498013153105153199217
397(6):21847498013153104153177227253270
529–39.24787498013154104155212261311326